Ben Axler

Private Equity Investor chez DRI Capital, Inc.

Profil

Ben is a life sciences commercial strategy professional with over 8 years of industry experience.
Ben joined DRI Healthcare in 2018 and is a leader in DRI’s business development function and is an active member of DRI Healthcare’s Investment Team.
Prior to joining DRI Healthcare, Ben spent 2 years in management consulting in Boston with Promidian (now Eversana), a boutique life sciences advisory firm.
Ben graduated from the Keck Graduate Institute (KGI) in Claremont California with a Masters of Business and Science (MBA/MSc) majoring in Biotech Management.
In his time in California, Ben worked in a variety of roles across the life sciences value chain; including portfolio optimization with Thermo Fisher, strategic marketing with Roche, clinical trial planning with Pfizer, and market research for Children’s Hospital of Los Angeles (CHLA).
Prior to his time in California, Ben worked as an operations associate at a clinical trials research center in Toronto and interned at the University of Toronto (U of T) in the Innovations and Partnerships Office (technology transfer).
Ben completed an Honors Bachelor of Science (H.BSc) with a specialization in Genetics and Biochemistry at Western University in London, Ontario, Canada.

Postes actifs de Ben Axler

Sociétés	Poste	Début
DRI Capital, Inc.	Private Equity Investor	01/06/2020

Formation de Ben Axler

Keck Graduate Institute of Applied Life Sciences	Masters Business Admin
Western University	Undergraduate Degree